Drug Metabolism Letters
Title:Meet Our Editorial Board Member
Volume: 10 Issue: 4
Author(s): Albert P. Li
Affiliation:
Export Options
About this article
Cite this article as:
Li P. Albert, Meet Our Editorial Board Member, Drug Metabolism Letters 2016; 10 (4) . https://dx.doi.org/10.2174/187231281004170315182757
DOI https://dx.doi.org/10.2174/187231281004170315182757 |
Print ISSN 1872-3128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-0758 |
14
Related Articles
-
Myostatin Inhibition and Cardiometabolic Disorders
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Novel Interpenetrating Polymer Matrix Network Microparticles for Intestinal Drug Delivery
Current Drug Delivery Pharmacological Treatments for Neovascular Age-Related Macular Degeneration: Can Mixed Treatment Comparison Meta-Analysis be Useful?
Current Drug Targets Dietary Polyphenols for Prostate Cancer Therapy
Current Bioactive Compounds Endocrinological Aspects of Proteinuria and Podocytopathy in Diabetes: Role of the Aldosterone/Mineralocorticoid Receptor System
Current Diabetes Reviews Celiac Disease: Pathogenesis and Novel Therapeutic Strategies
Endocrine, Metabolic & Immune Disorders - Drug Targets Nanotechnology on Duty in Medical Applications
Current Pharmaceutical Biotechnology Neurotrophins Role in Depression Neurobiology: A Review of Basic and Clinical Evidence
Current Neuropharmacology Inhibitory Effects of Cathepsin K Inhibitor (ODN-MK-0822) on the Paracrine Pro-Osteoclast Factors of Breast Cancer Cells
Current Molecular Pharmacology p53 Peptide Prevents LITAF-Induced TNF-Alpha-Mediated Mouse Lung Lesions and Endotoxic Shock
Current Molecular Medicine Targeting miRNAs for Drug Discovery: A New Paradigm
Current Molecular Medicine Probiotics and Immune Regulation of Inflammatory Bowel Diseases
Current Drug Targets - Inflammation & Allergy Animal Models For Craniofacial Reconstruction by Stem/Stromal Cells
Current Stem Cell Research & Therapy Oxidative DNA Damage and Oxidant/Anti-Oxidant Enzymatic Systems in Carcinogenesis and Cancer Progression
Current Enzyme Inhibition Genomic Strategies in Transplantation “The Right Drug for the Right Patient”
Current Pharmacogenomics Biospecific Interaction Analysis (BIA) as a Tool for the Design and Development of Gene Transcription Modifiers
Current Medicinal Chemistry - Anti-Cancer Agents Deciphering Subtype-Selective Modulations in TRPA1 Biosensor Channels
Current Neuropharmacology Inhaled KMUP-1 Prevents Allergic Pulmonary Vascular Inflammation and Remodeling via NO and Suppressed MMP-9 and ICAM-1/VCAM-1
Inflammation & Allergy - Drug Targets (Discontinued) Treatment of Nasopharyngeal Carcinoma: Therapeutic Management and Future View of Epstein-Barr Virus-Targeting Treatment
Current Cancer Therapy Reviews Hydrogen Sulfide: A New Tool to Design and Develop Drugs
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued)